Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma Mark P. Chao, Ash A. Alizadeh, Chad Tang, June.

Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma

Mark P. Chao, Ash A. Alizadeh, Chad Tang, June H. Myklebust, Bindu Varghese, Saar Gill, Max Jan, Adriel C. Cha, Charles K. Chan, Brent T. Tan, Christopher Y. Park, Feifei Zhao, Holbrook E. Kohrt, Raquel Malumbres, Javier Briones, Randy D. Gascoyne, Izidore S.

Lossos, Ronald Levy, Irving L. Weissman, Ravindra Majeti

Cell Volume 142, Issue 5, Pages 699-713 (September 2010)

DOI: 10.1016/j.cell.2010.07.044

Copyright © 2010 Elsevier Inc. Terms and Conditions

http://www.elsevier.com/termsandconditions

Figure 1

Cell 2010 142, 699-713DOI: (10.1016/j.cell.2010.07.044) Copyright © 2010 Elsevier Inc. Terms and Conditions


Figure 2



Figure 3



Figure 4



Figure 5



Figure 6



Figure 7



Figure S1



Figure S2



Figure S3



Figure S4



Figure S5



Figure S6



Figure S7





Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma Mark P. Chao, Ash A. Alizadeh, Chad Tang, June.

Documents

conditionsfigure s1

conditionsfigure s2

conditionsfigure s3

conditionsfigure s4

conditionsfigure s5

conditionsfigure s6

conditionsfigure s7

cell size